European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Haupt Pharma Amareg GmbH, Regensburg, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Haupt Pharma Amareg GmbH
AMAREG GmbH

Identification

Ut
District Court of Regensburg HRB 9285
Ut
District Court of Iserlohn HRB 3176
EUID
DED3410V.HRB9285

Address

Donaustaufer Str. 378, 93055 Regensburg, Germany

Corporate purpose

Development, manufacture, packaging and distribution as well as testing and quality control of pharmaceuticals, medical devices and dietary supplements of all kinds as well as pharmaceutical, cosmetic and dietary products of all kinds (including the distribution of the aforementioned services and trade of the aforementioned products as well as their import and export), approval of medicinal products as well as acquisition and trade in marketing and trade in marketing authorisations of medicinal products as well as acquisition, holding and management of Investments as well as purchasing and … Show more

History

Persons

Network

Loading network

Publications

3 Jul 2025 via Apollo 5 GmbH also 31/07/2024, 29/07/2015
Shareholder: Apollo 5 GmbH
6 Jun 2025
No longer Managing Director: Oliver Schmied · No longer Authorized signatory (ppa): Kim Sven Messer
5 Mar 2025
Managing Director: Nancy Thiels
21 Jan 2025
Authorized signatory (ppa): Philipp M. Ponton, Philipp M. Schäfer
17 Dec 2024
Share­holder agreement
12 Dec 2024
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Jun 2024
Share­holder agreement
13 Jun 2024
Original document: “Gesellschaftsvertrag / Satzung / Statut“
6 Mar 2024
Managing Director: Jan Kengelbach · No longer Managing Director: Roelof C. de Nobel
28 Jul 2023
No longer Managing Director: Ralf Schuler
16 Jun 2023
No longer Authorized signatory (ppa) (1)
2 May 2023
Managing Director: Roelof C. de Nobel
24 Oct 2019
Company statute · Development, manufacture, packaging and distribution as well as testing and quality control of pharmaceuticals, medical devices and dietary supplements of all kinds as well as …
16 Sept 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 Jul 2019
Authorized signatory (ppa): Robert M. Richter
11 Oct 2018
Managing Director: Ralf Schuler
28 Jun 2018
No longer Managing Director: Christian Ewers
7 Jun 2018
No longer Managing Director: Mohammad Bagherpour
17 May 2018
Managing Director: Christian Ewers · No longer Managing Director: Mohammad Naraghi · No longer Authorized signatory (ppa) (1)
29 Nov 2017
Original document: “Liste der Gesellschafter“
9 Sept 2017
Managing Director: Mohammad Bagherpour · No longer Managing Director: Markus Böning · Authorized signatory (ppa) (1)
30 Apr 2016
Authorized signatory (ppa) (1)
25 Mar 2016
Managing Director: Markus Böning
20 Apr 2015 via Haupt Pharma AG also 04/02/2015, 19/08/2013, 12/08/2013, 22/10/2012, 16/10/2012, 01/08/2011, 24/01/2011, 04/10/2010, 11/03/2010, 29/01/2010
Shareholder: Haupt Pharma AG
29 Jan 2015
Authorized signatory (ppa): Ralph Meyer
1 Sept 2014
Original document: “Liste der Gesellschafter“
28 Mar 2013
No longer Managing Director (1)
20 Mar 2013
No longer Managing Director (1)
7 Feb 2013
Managing Director: Oliver Schmied · No longer Authorized signatory (ppa): Oliver Schmied
30 Jan 2013
Managing Director: Oliver Schmied · No longer Authorized signatory (ppa): Oliver Schmied
1 Aug 2012 via INVITA AG also 01/08/2012, 01/08/2012, 01/08/2012, 08/05/2012, 03/05/2012, 03/05/2012, 23/04/2012
Shareholder: INVITA AG
29 Mar 2012
Authorized signatory (ppa): Kim Sven Messer
16 Mar 2011
Company statute
3 Mar 2011
Company statute
27 Dec 2010
Original document: “Gesellschaftsvertrag / Satzung / Statut“
25 Aug 2010
Managing Director (1) · No longer Managing Director (1)
16 Aug 2010
Managing Director (1) · No longer Managing Director (1)
18 Feb 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
25 Nov 2009
Control: Haupt Pharma AG · Control: Haupt Pharma AG
13 Nov 2009
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
23 Jul 2009
Authorized signatory (ppa): Elisabeth Drobner, Oliver Schmied
9 Mar 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
11 Feb 2009
Managing Director (1) · No longer Managing Director (1) · No longer Authorized signatory (ppa) (1) · Address
19 Sept 2008
Name: Haupt Pharma Amareg GmbH · Company statute
12 Aug 2008 as AMAREG GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
1 Jul 2008 as AMAREG GmbH
Original document: “Liste der Gesellschafter“
1 Jul 2008 as AMAREG GmbH
Original document: “Liste der Gesellschafter“
9 Apr 2008 as Amareg GmbH
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
11 Oct 2007 as AMAREG GmbH
No longer Managing Director (1)
10 Aug 2007 as AMAREG GmbH
Authorized signatory (ppa): Elisabeth Drobner
2 Aug 2007
Authorized signatory (ppa): Elisabeth Drobner
11 Oct 2005 as AMAREG GmbH
Authorized signatory (ppa) (1)
27 Jan 2005 as AMAREG GmbH
Original document: “Liste der Gesellschafter“
27 Jan 2005
Original document: “Liste der Gesellschafter“
19 Apr 2004
Managing Director (1)
24 Feb 2004
Change of headquarters: AMAREG GmbH · Seat: Regensburg, Germany
18 Feb 2004 as AMAREG GmbH
Reg­is­tra­tion · MD (2) · Capital: €25,000 · Seat: Plettenberg, Germany · Legal form · Name: AMAREG GmbH · Gegenstand des Unternehmens ist die Verwaltung eigenen Vermögens, der Erwerb und die …
10 Feb 2004 as AMAREG GmbH
MD (2) · Change of headquarters · Capital: €100,000 · Seat: Regensburg · Legal form · Name: AMAREG GmbH · Proxy policy · Company statute …
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Haupt Pharma Amareg GmbH, Regensburg, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.